Cathie Wood's Ark Invest sold shares in UiPath, Prime Medicine, and Repare Therapeutics, with notable gains and losses.

Cathy Wood, chief executive of ARKK Invest, is a celebrity in the world of finance. Her company offers an array of exchange traded funds (ETF), and the best-known fund among them is the ARK Innovation ...

According to ARK’s daily trading disclosure for April 4, Wood’s flagship ARK Innovation ETF (ARKK) bought nearly 55,000 ...

Whenever there is a new trend, ARKK often buys the stock only when everyone has done so too. This makes the ETF vulnerable to buying into bubbles. While it is normal for funds that buy into ...

ARK Invest CEO Cathie Wood maintains her ambitious $2,600 price target for Tesla (NASDAQ:TSLA) by 2029—valuing the company at ...

Cathie Wood’s Ark Innovation ETF (NYSEARCA:ARKK) is a tech ETF to avoid. While it was one of the primary reasons the investing guru shot to fame and the stock market’ consciousness after ARKK ...

Given the current sharp selloff in markets, how have traditional diversifiers performed? Tail Hedging turned out to be quite ...

The stock is a top holding in the Ark Innovation ETF (ARKK), which is down about 11% so far in 2024. Ark Invest CEO and CIO Cathie Wood says of the upcoming event, "Tesla is giving us great ...

Earlier this week, the ARKK ETF purchased 269,864 shares of HOOD stock, reflecting Wood’s confidence in the online brokerage platform. Additionally, the ARKK ETF and the ARK Genomic Revolution ...